<scp>Health‐related</scp> quality of life outcomes in <scp>PARAGON‐HF</scp>-Reference-Cited by-同舟云学术

Health‐related quality of life outcomes in PARAGON‐HF

Published:2022-12 Issue:12 Volume:24 Page:2264-2274
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Chandra Alvin¹,Polanczyk Carisi A.²,Claggett Brian L.³,Vaduganathan Muthiah³,Packer Milton⁴,Lefkowitz Martin P.⁵,Rouleau Jean L.⁶,Liu Jiankang³,Shi Victor C.⁵,Schwende Heike⁵,Zile Michael R.⁷,Desai Akshay S.³,Pfeffer Marc A.³,McMurray John J.V.⁸,Solomon Scott D.³,Lewis Eldrin F.⁹

Affiliation:

1. Division of Cardiology University of Texas Southwestern Medical Center Dallas TX USA

2. Federal University of Rio Grande do Sul Porto Alegre Brazil

3. Brigham and Women's Hospital Boston MA USA

4. Baylor Heart and Vascular Institute, Baylor University Medical Center Dallas TX USA

5. Novartis East Hanover NJ USA

6. Institut de Cardiologie de Montreal, Université de Montreal Canada Montreal Canada

7. RHJ Department of Veterans Administration Medical Center Medical University of South Carolina Charleston SC USA

8. BHF Cardiovascular Research Centre University of Glasgow Glasgow UK

9. Cardiovascular Division Stanford University School of Medicine Palo Alto CA USA

Funder

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2738

Reference25 articles.

2. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM

3. Quality of life and outcomes in heart failure patients with ejection fractions in different ranges

4. Identifying Patients Hospitalized With Heart Failure at Risk for Unfavorable Future Quality of Life

5. Assessing the Impact of Heart Failure Therapeutics on Quality of Life and Functional Capacity

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weekly Journal Scan: a ‘thousand-mile’ journey in obesity-related heart failure treatment begins with a few STEPs;European Heart Journal;2024-07-10

2. Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan;Pharmacia;2024-06-27

3. Divergent cardiac and renal effects of miR-181c-5p inhibition in a rodent heart failure model;Frontiers in Cardiovascular Medicine;2024-04-25

4. High-Intensity Care Versus GDMT Titration: Which Rapidly Improves Health Status in Patients With Heart Failure?;Circulation: Heart Failure;2024-04

5. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction;European Journal of Pharmacology;2023-12